Tris trial is registered with FDA with number: NCT01732107. The sponsor of the trial is Noah Hahn, M.D. and it is looking for 13 volunteers for the current phase.
Official trial title:
A Phase II Trial of Dovitinib in Bacillus Calmette-Guerin(BCG) Refractory Urothelial Carcinoma Patients With Tumor Fibroblast Growth Factor Receptor 3(FGFR3) Mutations or Over-expression: Hoosier Cancer Research Network GU12-157